(Q54260230)

26 May 2018

title

Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients. (English)

1 reference

26 May 2018

1 reference

7

1 reference

26 May 2018

author name string

An Na Seo

1

1 reference

26 May 2018

Kyoung Un Park

2

1 reference

26 May 2018

Gheeyoung Choe

3

1 reference

26 May 2018

Woo Ho Kim

4

1 reference

26 May 2018

Duck-Woo Kim

5

1 reference

26 May 2018

Sung-Bum Kang

6

1 reference

26 May 2018

publication date

10 July 2015

1 reference

26 May 2018

published in

Tumor Biology

1 reference

26 May 2018

volume

36

1 reference

26 May 2018

issue

12

1 reference

26 May 2018

page(s)

9813-9821

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3726-2

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

MET: a promising anticancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Protein expression profiling and molecular classification of gastric cancer by the tissue array method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Microsatellite instability testing in Korean patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Tissue microarrays in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3726-2

Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors

21 January 2018

1 reference

12 December 2020

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

1 reference

12 December 2020

c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma

1 reference

12 December 2020

Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization

1 reference

12 December 2020

c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.

1 reference

12 December 2020

HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression

1 reference

12 December 2020

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

1 reference

12 December 2020

Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures

1 reference

12 December 2020

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

1 reference

12 December 2020

Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.

1 reference

12 December 2020

10.1007/S13277-015-3726-2

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018